Home > Publications database > Regorafenib in glioblastoma recurrence: how to deal with conflicting 'real-life' experiences? > print

001     148920
005     20240229120021.0
024 7 _ |a 10.1177/1758835919887667
|2 doi
024 7 _ |a pmid:31897090
|2 pmid
024 7 _ |a pmc:PMC6918487
|2 pmc
024 7 _ |a 1758-8340
|2 ISSN
024 7 _ |a 1758-8359
|2 ISSN
024 7 _ |a altmetric:124363361
|2 altmetric
037 _ _ |a DKFZ-2020-00078
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Glas, Martin
|0 P:(DE-He78)a44ef83e4213638f939d4e35a3c52d34
|b 0
245 _ _ |a Regorafenib in glioblastoma recurrence: how to deal with conflicting 'real-life' experiences?
260 _ _ |a Thousand Oaks, Calif.
|c 2019
|b Sage
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1581516612_31356
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a EAL401LAL401
536 _ _ |a 899 - ohne Topic (POF3-899)
|0 G:(DE-HGF)POF3-899
|c POF3-899
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Kebir, Sied
|0 P:(DE-He78)e6bbfbfebf0444562d54516969dde039
|b 1
773 _ _ |a 10.1177/1758835919887667
|g Vol. 11, p. 175883591988766 -
|0 PERI:(DE-600)2503443-1
|p 175883591988766 -
|t Therapeutic advances in medical oncology
|v 11
|y 2019
|x 1758-8359
909 C O |p VDB
|o oai:inrepo02.dkfz.de:148920
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)a44ef83e4213638f939d4e35a3c52d34
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)e6bbfbfebf0444562d54516969dde039
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF3-890
|0 G:(DE-HGF)POF3-899
|2 G:(DE-HGF)POF3-800
|v ohne Topic
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b THER ADV MED ONCOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC (No Version)
|0 LIC:(DE-HGF)CCBYNCNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b THER ADV MED ONCOL : 2017
920 1 _ |0 I:(DE-He78)L401-20160331
|k L401
|l DKTK Essen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)L401-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21